Patents by Inventor Kathryn J. Elliott
Kathryn J. Elliott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8932539Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.Type: GrantFiled: December 20, 2013Date of Patent: January 13, 2015Assignee: Pathway Genomics CorporationInventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
-
Publication number: 20140205516Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.Type: ApplicationFiled: December 20, 2013Publication date: July 24, 2014Applicant: PATHWAY GENOMICS CORPORATIONInventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
-
Patent number: 8617487Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.Type: GrantFiled: March 25, 2009Date of Patent: December 31, 2013Assignee: Venture lending & Leasing VI, Inc.Inventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
-
Publication number: 20120325721Abstract: Saliva sample collection systems are configured with special attention to ease-of-use for the unskilled user and safe transport and delivery by a conventional delivery services such as Federal Express. A sealed cavity is formed by tight coupling of two primary elements: a receiving vessel element and a sealing cap element. The receiving vessel has integrated therewith: a standing means, a fill-line window, a funnel system, a knife, a threadset, and containment tube among others. A complementary cap element includes a cooperating threadset, label receiving surface, gripping surface, seal means and reservoir with piercable thin-film membrane. These two primary elements may be accommodated in an application-specific shipping container which support two shipping modes whereby the system may be shipped safely to and from a donor user each way in a different shipping mode.Type: ApplicationFiled: March 25, 2009Publication date: December 27, 2012Inventors: James Plante, David Becker, Edgar MacBean, Kathryn J. Elliott
-
Patent number: 7169895Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically ?6) and beta subunits (specifically ?3) are provided. In addition, combinations of a plurality of subunits (i.e., one or more of ?1, ?2, ?3, ?4, ?5, ?6 and/or ?7 subunits in combination with one or more of ?3 subunits are provided.Type: GrantFiled: November 25, 2002Date of Patent: January 30, 2007Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Patent number: 7119067Abstract: Nucleic acid molecules encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the nucleic acid molecules, and methods for producing alpha and beta subunits are provided. In particular, nucleic acid molecules encoding ?6 subunits and molecules encoding ?3 subunits of human neuronal nicotinic acetylcholine receptors are provided. In addition, combinations of a plurality of subunits, such as one or more of ?1, ?2, ?3, ?4, ?5, ?6 and/or ?7 subunits in combination with one or more of ?3 subunits or such as one or more of ?2, ?3 and/or ?4 subunits in combination with an ?6 subunit are provided.Type: GrantFiled: January 23, 2003Date of Patent: October 10, 2006Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Patent number: 6936457Abstract: Isolated nucleic acid molecules, i.e., DNA or RNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing ? and ? subunits and recombinant (i.e., isolated or substantially pure) ? subunits and ? subunits are provided. In addition, cells expressing various multimeric combinations of subunits (i.e., ?1, ?2 ?3 ?4 ?5 ?6 and/or ?7 in combination with at least one of an ? and ? subunit are also provided. A recombinant, non-human cell line expressing the human ?7 subunit of nAChR is disclosed.Type: GrantFiled: November 1, 2000Date of Patent: August 30, 2005Assignee: Merck & Co., Inc.Inventors: Allison Gillespie, Brian O. Claeps, Laura Elena Chavez-Noriega, Robert Siegel, Kathryn J. Elliott
-
Publication number: 20040002122Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically &agr;6) and beta subunits (specifically &bgr;3) are provided. In addition, combinations of a plurality of subunits (i.e., one or more of &agr;1, &agr;2, &agr;3, &agr;4, &agr;5, &agr;6 and/or &agr;7 subunits in combination with one or more of &bgr;3 subunits are provided.Type: ApplicationFiled: November 25, 2002Publication date: January 1, 2004Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Patent number: 6664375Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the DNA, methods for producing &agr; and &bgr; subunits and isolated or substantially pure &agr;4, &agr;7 and &bgr;4 subunits are provided. In addition, cells that expresses these subunits singly or combination with other subunits of nicotinic acetylcholine receptors and methods using the cells are provided.Type: GrantFiled: June 27, 2001Date of Patent: December 16, 2003Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Publication number: 20030170678Abstract: Genetic markers associated with Alzheimer's disease are provided. Also provided are methods of determining the presence or absence in a subject of one or more polymorphisms associated with Alzheimer's disease and methods of determining the level of risk for Alzheimer's disease in a subject. Further provided are nucleic acid compositions and kits for use in determining the presence or absence in a subject of one or more polymorphisms associated with Alzheimer's disease and kits for determining the level of risk for Alzheimer's disease in a subject.Type: ApplicationFiled: October 25, 2002Publication date: September 11, 2003Applicant: Neurogenetics, Inc.Inventors: Rudolph E. Tanzi, Kenneth David Becker, Gonul Velicelebi, Kathryn J. Elliott, Xin Wang, Lars Bertram, Aleister J. Saunders, Deborah Lynne Blacker
-
Publication number: 20030138911Abstract: Nucleic acid molecules encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the nucleic acid molecules, and methods for producing alpha and beta subunits are provided. In particular, nucleic acid molecules encoding &agr;6 subunits and molecules encoding &bgr;3 subunits of human neuronal nicotinic acetylcholine receptors are provided. In addition, combinations of a plurality of subunits, such as one or more of &agr;1, &agr;2, &agr;3, &agr;4, &agr;5, &agr;6 and/or &agr;7 subunits in combination with one or more of &bgr;3 subunits or such as one or more of &bgr;2, &bgr;3 and/or &bgr;4 subunits in combination with an &agr;6 subunit are provided.Type: ApplicationFiled: January 23, 2003Publication date: July 24, 2003Applicant: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Patent number: 6524789Abstract: Nucleic acid molecules encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the nucleic acid molecules, and methods for producing alpha and beta subunits are provided. In particular, nucleic acid molecules encoding &agr;6 subunits and molecules encoding &bgr;3 subunits of human neuronal nicotinic acetylcholine receptors are provided. In addition, combinations of a plurality of subunits, such as one or more of &agr;1, &agr;2, &agr;3, &agr;4, &agr;5, &agr;6 and/or &agr;7 subunits in combination with one or more of &bgr;3 subunits or such as one or more of &bgr;2, &bgr;3 and/or &bgr;4 subunits in combination with an &agr;6 subunit are provided.Type: GrantFiled: June 7, 1996Date of Patent: February 25, 2003Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Publication number: 20020177120Abstract: Recombinant cells expressing fluorescence resonance energy transfer reporter polypeptides and cell-based assays for apoptosis; screening assays for identifying and selecting candidate compounds modulating apoptosis.Type: ApplicationFiled: June 4, 1999Publication date: November 28, 2002Inventors: KATHRYN J. ELLIOTT, MARIA Z. KOUNNAS, REBECCA J. DYER, BENITO MUNOZ, STEVEN L. WAGNER
-
Patent number: 6485967Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically &agr;6) and beta subunits (specifically &bgr;3) are provided. In addition, combinations of a plurality of subunits (i.e., one or more of as &agr;1, &agr;2, &agr;3, &agr;4, &agr;5, &agr;6 and/or &agr;7 subunits in combination with one or more of &bgr;3 subunits are provided.Type: GrantFiled: June 7, 1995Date of Patent: November 26, 2002Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Michael M. Harpold
-
Patent number: 6440681Abstract: Methods for identifying compounds which modulate the activity of human neuronal nicotinic acetylcholine receptors are provided. Invention methods employ DNAs encoding alpha and beta subunits of human neuronal nicotinic acetylcholine receptors, and the polypeptides encoded thereby. Test cells useful for conducting invention assays include mammalian and amphibian cells containing said DNA. Various combinations of subunits (i.e., one or more &agr;2, &agr;3, &agr;4, &agr;5, &agr;6 and &agr;7 subunits in combination with &bgr;2, &bgr;3 and/or &bgr;4 subunits) can be employed for the invention assays.Type: GrantFiled: June 7, 1995Date of Patent: August 27, 2002Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Publication number: 20020111463Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the DNA, methods for producing &agr; and &bgr; subunits and isolated or substantially pure &agr;4, &agr;7 and &bgr;4 subunits are provided. In addition, cells that expresses these subunits singly or combination with other subunits of nicotinic acetylcholine receptors and methods using the cells are provided.Type: ApplicationFiled: June 27, 2001Publication date: August 15, 2002Applicant: MERCK & CO., INC.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Patent number: 6303753Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing the DNA, methods for producing &agr; and &bgr; subunits and isolated or substantially pure &agr;4, &agr;7 and &bgr;4 subunits are provided. In addition, cells that expresses these subunits singly or combination with other subunits of nicotinic acetylcholine receptors and methods using the cells are provided.Type: GrantFiled: December 21, 1998Date of Patent: October 16, 2001Assignee: Merck & Co., Inc.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Patent number: 6022704Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically .alpha..sub.4 and .alpha..sub.7) and beta subunits (specifically .beta..sub.4) are provided. In addition, combinations of subunits (i.e., .alpha..sub.1, .alpha..sub.2, .alpha..sub.3, .alpha..sub.4, and/or .alpha..sub.7 subunits in combination with .beta..sub.4 subunits; or .beta..sub.2, .beta..sub.3 and/or .beta..sub.4 subunits in combination with .alpha..sub.4 and/or .alpha..sub.7 subunits) are provided.Type: GrantFiled: June 5, 1995Date of Patent: February 8, 2000Assignee: SIBIA Neurosciences, Inc.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Patent number: 5910582Abstract: Nucleic acid encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically .alpha..sub.4 and .alpha..sub.7) and beta subunits (specifically .beta..sub.4) are provided. In addition, combinations of subunits (i.e., .alpha..sub.1, .alpha..sub.2, .alpha..sub.3, .alpha..sub.4, and/or .alpha..sub.7 subunits in combination with .beta..sub.4 subunits; or .beta..sub.2, .beta..sub.3 and/or .beta..sub.4 subunits in combination with .alpha..sub.4 and/or .alpha..sub.7 subunits) are provided.Type: GrantFiled: July 16, 1996Date of Patent: June 8, 1999Assignee: SIBIA Neurosciences, Inc.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold
-
Patent number: 5837489Abstract: DNA encoding human neuronal nicotinic acetylcholine receptor alpha and beta subunits, mammalian and amphibian cells containing said DNA, methods for producing alpha and beta subunits and recombinant (i.e., isolated or substantially pure) alpha subunits (specifically .alpha..sub.4 and .alpha..sub.7) and beta subunits (specifically .beta..sub.4) are provided. In addition, combinations of subunits (i.e., .alpha..sub.1, .alpha..sub.2, .alpha..sub.3, .alpha..sub.4, and/or .alpha..sub.7 subunits in combination with .beta..sub.4 subunits; or .beta..sub.2, .beta..sub.3 and/or .beta..sub.4 subunits in combination with .alpha..sub.4 and/or .beta..sub.7 subunits) are provided.Type: GrantFiled: June 5, 1995Date of Patent: November 17, 1998Assignee: SIBIA Neurosciences, Inc.Inventors: Kathryn J. Elliott, Steven B. Ellis, Michael M. Harpold